Radvany P, Pine M, Weintraub R, Abelmann W H, Bernhard W F
J Thorac Cardiovasc Surg. 1978 Jan;75(1):97-103.
A 38-year-old white woman had cardiogenic shock after elective mitral valve replacement and was unresponsive to pressor drugs and intra-aortic balloon counterpulsation. A left ventricular assist device (left ventricle to ascending aorta) was implanted 16 hours after the initial operation and provided circulatory support for 8 days. Improvement in the patient's own cardiac performance was documented, and there were no complications attributable to the assist device. However, intercurrent medical problems resulted in clinical deterioration on the fifth day after operation, and the patient died 8 days after operation. The findings in this patient suggest a potential role for this left ventricular assist device in future cases of acute, intractable, but potentially reversible myocardial failure.
一名38岁的白人女性在择期二尖瓣置换术后发生心源性休克，对升压药和主动脉内球囊反搏无反应。在初次手术后16小时植入了左心室辅助装置（从左心室到升主动脉），并提供了8天的循环支持。记录显示患者自身心脏功能有所改善，且没有可归因于辅助装置的并发症。然而，术后第五天并发的医疗问题导致临床病情恶化，患者于术后8天死亡。该患者的情况表明，这种左心室辅助装置在未来急性、难治性但可能可逆的心肌衰竭病例中可能发挥潜在作用。
